Linda Rabin Judge

Linda Rabin Judge

0.0
Not yet reviewed Write a Review

Licensed for 28 years

Estate planning Lawyer at San Francisco, CA
Practice Areas: Estate Planning

153 Townsend Street Suite 800, San Francisco, CA

Claim Profile

Is this your profile? Claiming it is free and only takes 2 minutes.

About Linda

Practice Areas

1

Practice Area

Fees and Rates

We have not found any cost information for this lawyer


Looking for an attorney? Avvo can help.

search module image

Search our directory

Quickly connect with top attorneys through our legal directory to get help with your legal issue.

chat module image

Avvo's live chat agents can help coordinate a consultation with a local attorney.

Chat with a live agent who can match you with the right attorney for your legal needs.

Chat with

Licenses

Licensed in California for 28 years

State: California

Acquired: 1997

Active

No misconduct found

Location

DLA Piper US LLP

153 Townsend Street Suite 800, San Francisco, CA, 94107-1957

Wakeup Legal

Po Box 1464, Blrsdn Greagl, CA, 96103-1464

Ad

Transform legal challenges into solutions.

Connect now to review your situation.

The Avvo Rating explained

display-bg

The Avvo Rating explained

Linda Rabin Judge's Reviews

Avvo Review Score

0.0 /5.0

Not Yet Reviewed

Linda Rabin Judge's Lawyer Endorsements

Endorse Linda

No Endorsement Data Available Yet
This attorney hasn't received any attorney endorsements recently on Avvo.

No Endorsement Data Available Yet
This attorney hasn't created any attorney endorsements recently on Avvo.

Experience

Associations

American Intellectual Property Law Association

Member

National Association of Patent Practitioners

Member

Education

1997

Santa Clara University School of Law

JD - Juris Doctor

1984

University of California - Berkeley

MS - Master of Science

1980

California State University, Sonoma State University

BA - Bachelor of Arts

1980

California State University, Sonoma State University

BS - Bachelor of Science

Speaking Engagements

2006

ACI meeting on Biotech/Pharma Collaborative Agreements

IP Due Diligence in Biotech Pharma Collaborative Agreements

2006

Meeting On Life Sciences Due Diligence

Life Sciences IP Due Diligence for M&As, Licensing, and Other Collaborations

2006

ACI meeting on Maximizing Pharmaceutical Patent Life Cycles

Patent Term Extension

2005

National Association of Patent Practitioners Annual Meeting

Patenting Research Tools

2005

Kauffman Fellows Program

IP Diligence and Strategy

2005

University of California at Berkeley Haas School of Business Center for Executive Development Global BioExecutive Program

Intellectual Property

Publications

2003

Santa Clara Computer and High Technology Law Journal Highlights of Science and Law Shaping the Industry

1998

Antimicrob Agents Chemother Inhibition of human immunodeficiency virus type 1 infection in SCID-hu Thy/Liv mice by the G-quartet-forming oligonucleotide

1997

Unknown Identification of HIV-1 determinants for replication in vivo

1996

Santa Clara Computer and High Technology Law Journal Issues Surrounding The Patenting of Medical Procedures

1996

Antimicrobial Agents and Chemotherapies Preclinical Evaluation of a Bicyclam

1996

Antimicrobial Agents and Chemother A Standardized Small Animal Model for Preclinical Efficacy Testing of Anti HIV-1 Compounds

1995

Immunity Induced Thymocyte Depletion is Associated with Indirect Cytopathicity and Infection of Progenitor Cells in Vivo

1993

Unknown HIV Induces Thymus Depletion in vivo

1991

Annu. Rev. Immunol. The SCID-hu Mouse: A Small Animal Model for HIV Infection and Pathogenesis

1991

J. Infec. Disease Post exposure Prophylaxis with Zidovudine Suppresses Human Immunodeficiency Virus Type I Infection In SCID-hu Mice in a Time-Dependent Manner

1991

Proc. Nat. Acad. Sci. HIV Infection of Lymph Nodes in the SCID-hu Mouse: A Useful Small Animal Model for Testing the Efficacy of Antiviral Compounds

1990

Annals of New York Acad Preclinical Testing of Antivirals Against the Human Immunodeficiency Virus in the SCID-hu Mouse

1990

Science Suppression of HIV Infection in AZT-treated SCID-hu mice

1990

Unknown Today's SCID-hu Mouse

1990

Science Pseudotypes in HIV-Infected Mice

1990

Science Suppression of HIV Infection in AZT-treated SCID-hu mice

1989

J. Infec. Dis Human Monoclonal Antibodies to Cytomegalovirus

1989

Progress in Immunology The SCID-hu Mouse: A Small Animal Model for HIV infection and Antiviral Testing. Progress in Immunology

1988

Cell Endoproteolytic Cleavage of gp 160 is Required for the Activation of Human Immunodeficiency Virus

1987

J. Immunol. J. Characterization/Epitope Mapping of a Human Monoclonal Antibody Reactive with the Envelope Glycoprotein of HIV

1986

Unknown Induction of CD4 Dependent Cell Fusion by the HTLV III/LAV Envelope Glycoprotein

1985

J. Econ. Entomol. Reduced Larval Growth of two Lepidoptera (Noctuidae) on Excised Leaves of Soybean Infected with a Mycorrhizal Fungus

1983

A.C.S. Symposium Series AC Bio-regulation of Host Plant Resistance to Insects

1981

J. Chrom. Separation of Plant Polyphenolics by Chromatography on a Boronate Resin
Avvo Rating

Our Rating is calculated using information the lawyer has included on their profile in addition to the information we collect from state bar associations and other organizations that license legal professionals. Attorneys who claim their profiles and provide Avvo with more information tend to have a higher rating than those who do not.

What determines Avvo Rating?
  • Experience & background Years licensed, work experience, education
  • Legal community recognition Peer endorsements, associations, awards
  • Legal thought leadership Publications, speaking engagements
  • Discipline Disciplinary information may not be comprehensive, or updated. We recommend that you always check a lawyer's disciplinary status with their respective state bar association before hiring them.
Avvo Rating Levels
10.0 - 9.0 Superb8.9 - 8.0 Excellent7.9 - 7.0 Very Good6.9 - 6.0 Good5.9 - 5.0 Average4.9 - 4.0 Concern3.9 - 3.0 Caution2.9 - 2.0 Strong Caution1.9 - 1.0 Extreme Caution